Product Overview
Zyvex Pharmaceuticals sells Ligandrol as one hundred tablets of 10 mg, and the code on the label is the one most people know it by: LGD 4033. The molecule is a selective androgen receptor modulator, which means it is not a steroid at all in the structural sense, yet it still docks onto the androgen receptor and switches on the genes that receptor controls. That is how a tablet can add lean tissue without carrying the methyl group that makes oral steroids hard on the liver.
Two of its properties shape every plan built around it. It does not convert to estrogen, so there is no fluid retention and no breast tissue risk, and it does not need an aromatase inhibitor anywhere near it. And it suppresses the axis anyway, because the brain reads the androgen signal it creates as evidence that production is not needed. Published trial work recorded falls in total and free testosterone, in follicle stimulating hormone and in sex hormone binding globulin at doses far below the tablet sold here.
That gap between the research and the market is the honest starting point. Clinical studies ran repeated doses from 0.1 to 2 mg a day for three to twelve weeks, and one milligram a day added about 1.2 kg of lean mass over three weeks in healthy men. The grey-market range of 5 to 10 mg a day is several times higher, and the consequences of that scale are simply not documented. For scale, a weekly injection of Testosterone Esters supplies more androgen than the whole trial band of this tablet managed in three weeks, which is why the SARM line is usually placed beside a plan rather than in the middle of one.
Dosage Protocol
The table separates what was tested from what is used, because the two live in different worlds. No dose of this compound is approved anywhere.
| Level | Amount | Length | Note |
| Beginner | 5 mg daily | 8 weeks | Starts at the bottom of the grey-market band rather than at a trial dose |
| Intermediate | 5-10 mg daily | 8-12 weeks | The band seen most often, with testosterone and enzyme checks inside the course |
| Advanced | 10-15 mg daily | 8-12 weeks | Top of the range; nothing above this has been examined in humans |
| Female | Not confirmed | - | Masculinising effects in women are almost unstudied |
| Route | Oral tablet | Once daily | The 24 to 36 hour half-life holds a steady level with one tablet a day |
For context, a single 10 mg tablet is ten times the highest repeated dose used in the human studies that produced the lean mass figure quoted everywhere. That does not make it unsafe by default, and it does not make it safe either. It means the person taking it is the experiment, and monitoring is the only thing standing between a guess and a measurement.
Suggested Protocols
SARM plans are community constructions. Nothing below has been tested as a combination, and the pairings are offered as catalogue arrangements with the mechanism of each part made clear.
What to Expect
- Strength and lean mass creep up over the first two to three weeks, and the change is quiet compared with a steroid cycle.
- Body composition improves when protein and training are already in place; the tablet amplifies a plan rather than replacing one.
- Total and free testosterone, follicle stimulating hormone and sex hormone binding globulin fell in trial subjects, which is the mechanism behind the fatigue some users report late in a course.
- HDL drops while LDL behaviour in the same studies was unchanged, so the lipid picture becomes worse rather than mixed.
- Liver enzymes rose in the research, which is why a panel belongs inside a long course rather than after it.
- Regulators have flagged heart attack and stroke among the possible risks of this class, and no long-term human safety data exist for the amounts sold here.
Side Effects and Management
Post-Cycle Therapy
A SARM is not exempt from recovery. The tablet does not aromatise and it does not shut the axis down as hard as a strong injectable, but it does suppress it, and the published work shows that suppression at amounts below what is sold on the grey market. Because the compound clears in three to five days, the recovery window opens much sooner than it would after a decanoate.